🇺🇸 FDA
Patent

US 12173086

Alpha-v beta-6 integrin ligands and uses thereof

granted A61KA61K31/713A61K38/08

Quick answer

US patent 12173086 (Alpha-v beta-6 integrin ligands and uses thereof) held by Arrowhead Pharmaceuticals, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/713, A61K38/08, A61K47/60, A61K47/64